Theobromine is associated with slower epigenetic ageing

Area of Science:

• Nutritional Epidemiology
• Epigenetics
• Human Aging Research

Background:

• Theobromine, a cocoa-derived alkaloid, shows potential health benefits and lifespan extension in model organisms.
• Human studies suggest links between theobromine intake and improved health outcomes.

Purpose of the Study:

• To investigate the association between circulating theobromine levels and epigenetic markers of biological aging in human populations.
• To determine if theobromine's health benefits extend to molecular epigenetic aging processes.

Main Methods:

• Serum metabolomics was used to measure theobromine intake in two European population-based cohorts (TwinsUK and KORA).
• Epigenetic age acceleration was assessed using established biomarkers, GrimAge and DNA methylation-based telomere length (DNAmTL).
• Statistical analyses were performed to identify significant associations and replicate findings across cohorts.

Main Results:

• Higher serum theobromine levels were significantly associated with reduced epigenetic age acceleration, as measured by GrimAge and DNAmTL.
• These associations were robust and replicated in both the TwinsUK and KORA cohorts.
• Sensitivity analyses confirmed the specificity of theobromine's effect, independent of other cocoa and coffee metabolites.

Conclusions:

• Theobromine intake is associated with slower biological aging at the epigenetic level in humans.
• These findings provide molecular evidence supporting the beneficial effects of theobromine on health and aging.
• Theobromine may represent a dietary intervention target for promoting healthy aging.